Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation

American Journal of Pathology

Volumn 163, Issue 1, 2003, Pages 345-354

  Moodley, Yuben P ^a,b   Scaffidi, Amelia K ^a,b   Misso, Neil L ^a,b   Keerthisingam, Carmel ^c   McAnulty, Robin J ^c   Laurent, Geoff J ^c   Mutsaers, Steven E ^a,b   Thompson, Philip J ^a,b   Knight, Darryl A ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA ACTIN; CALPHOSTIN C; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NIMESULIDE; PROTEIN P19; PROTEIN P27; RETINOBLASTOMA PROTEIN; STAT3 PROTEIN; THYMIDINE; TRITIUM; WORTMANNIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOBLOTTING; LUNG DISEASE; LUNG FIBROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0038305966     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63658-9     Document Type: Article

References (36)

1. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP: Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157:199-203
2. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136-151
3. Selman M, Pardo A: Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 2002, 3:3
4. Mason RJ, Schwarz MI, Hunninghake GW, Musson RA: NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am J Respir Crit Care Med 1999, 160:1771-1777
5. Gauldie J: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 165:1205-1206
6. Coker RK, Laurent GJ: Pulmonary fibrosis: cytokines in the balance Eur Respir J 1998, 11:1218-1221
7. Kuhn C, McDonald JA: The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991, 138:1257-1265
8. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994, 145:114-125
9. Zhang HY, Gharaee-Kermani M, Phan SH: Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta. J Immunol 1997, 158:1392-1399
10. Zhang HY, Phan SH: Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999, 21: 658-665
11. Taga T: gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797-819
12. Taga T: The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 1997, 29: 63-72
13. Shahar I, Fireman E, Topilsky M, Grief J, Kivity S, Spirer Z, Ben Efraim S: Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases. Clin Immunol Immunopathol 1996, 79:244-251
14. Elias JA, Wu Y, Zheng T, Panattieri R: Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol 1997, 273:L648-L655
15. Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, Zitnik R, Ray P, Alderman EM: IL-11 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J Immunol 1994, 152:2421-2429
16. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA: Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998, 101:1970-1982
17. Orazi A, Du X, Yang Z, Kashai M, Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996, 75:33-42
18. DiCosmo BF, Geba GP, Picarella D, Elias JA, Rankin JA, Stripp BR, Whitsett JA, Flavell RA: Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 1994, 94:2028-2035
19. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriguez NA, Booth H, Laurent GJ, Hart SL, Foster ML, McAnulty RJ: Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001, 158: 1411-1422
20. Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA: Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci 2001, 114:3507-3516
21. Katzenstein AL, Myers J: Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998, 157:1301-1315
22. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalic-proteinases expression. Am J Respir Cell Mol Biol 2001, 24:591-598
23. Hadden H, Henke C: Induction of lung fibroblast apoptosis by soluble fibronectin peptides. Am J Respir Crit Care Med 2000, 162:1553-1560
24. Jordana M, Schulman J, McSharry C, Irving L, Newhouse M, Jordana G, Gauldie J: Heterogenous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis 1988, 137:579-584
25. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin 6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998, 334:297-314
26. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254
27. Kawaguchi Y, Hara M, Wright TM: Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A J Clin Invest 1999, 103:1253-1260
28. Nishimoto N, Ito A, Ono M Tagoh H, Matsumoto T, Tomita T, Ochi T, Yoshizaki K: IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol 2000, 12:187-293
29. Fries KM, Felch ME, Phipps RP: Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am J Respir Cell Mol Biol 1994, 11:552-560
30. Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T: STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 1998, 17:6670-6677
31. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T: A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996, 15:3651-3658
32. Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F: Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int 1999, 56: 1258-1261
33. Tang W, Geba GP, Zheng T, Ray P, Homer RJ, Kuhn CR, Flavell RA, Elias JA: Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 1996, 98:2845-2853
34. Zheng T, Zhu Z, Wang J, Homer RJ, Elias JA: IL-11: insights in asthma from overexpression transgenic modeling. J Allergy Clin Immunol 2001, 108:489-496
35. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M: Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1996, 96:1861-1868
36. McAnulty RJ, Hernandez-Rodriguez NA, Mutsaers SE, Coker RK, Laurent GJ: Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem J 1997, 321:639-643